EUVIMEDEUVIMED entdecken
Vergleichsstudie

Middle Pancreatectomy for Low‐Grade Malignancies: Superior Long‐Term Glucose Tolerance Preservation Over Distal Pancreatectomy

Atsuro Fujinaga iD, Minoru Esaki, Kei Kitamura, Ryosuke Umino, Takahiro Mizui, Akinori Miyata, Satoshi Nara

Journal of Hepato-Biliary-Pancreatic Sciences · 2026

DOI: 10.1002/jhbp.70121 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2026. Verfasst von Atsuro Fujinaga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Pancreatectomy, Pancreatic Neoplasms, Blood Glucose. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Cancer Center Research and Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study compared outcomes of middle pancreatectomy (MP) and distal pancreatectomy (DP), focusing on long‐term glucose tolerance.

Methods

We retrospectively reviewed 282 patients who underwent MP ( n = 69) or DP ( n = 213) for low‐grade malignant tumors from 2000 to 2020. Surgical outcomes, HbA1c levels, prevalence of diabetes mellitus (DM), and escalation of antidiabetic medication were analyzed.

Results

MP was associated with longer operation time (312 vs. 245 min, p < 0.001) and higher pancreatic fistula rate (64% vs. 47%, p = 0.018). Among 248 patients with 3‐year follow‐up, MP showed lower HbA1c levels (5.9% vs. 6.3%, p < 0.001), lower incidence of new‐onset DM (3% vs. 30%, p < 0.001), and fewer cases of increased antidiabetic medication use (8% vs. 24%, p = 0.005). Insulin therapy was newly required in 1 MP case versus 18 DP cases.

Conclusion

Despite higher morbidity, MP demonstrated superior preservation of long‐term glucose tolerance compared with DP. These findings suggest that MP is a valuable parenchyma‐preserving option for patients with low‐grade malignant pancreatic tumors, particularly those at increased risk of postoperative DM, although careful consideration of surgical risks is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatectomyPancreatic NeoplasmsBlood GlucoseHumansFemaleRetrospective StudiesMaleMiddle AgedAgedDiabetes MellitusTreatment OutcomePostoperative ComplicationsGlycated HemoglobinNeoplasm Grading

Stichwörter der Autor:innen

distal pancreatectomyglucose tolerancelow‐grade malignant pancreatic tumorsmiddle pancreatectomy

Substanzen

Glycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.

ORCID-Profile: Atsuro Fujinaga

Förderung

  • National Cancer Center Research and Development Fund

Zitieren

APA

Fujinaga, A., Esaki, M., Kitamura, K., Umino, R., Mizui, T., Miyata, A., & Nara, S. (2026). Middle Pancreatectomy for Low‐Grade Malignancies: Superior Long‐Term Glucose Tolerance Preservation Over Distal Pancreatectomy. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70121

Vancouver

Fujinaga A, Esaki M, Kitamura K, Umino R, Mizui T, Miyata A, et al. Middle Pancreatectomy for Low‐Grade Malignancies: Superior Long‐Term Glucose Tolerance Preservation Over Distal Pancreatectomy. Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70121

BibTeX
@article{Fujinaga2026,
  author = {Fujinaga, Atsuro and Esaki, Minoru and Kitamura, Kei and Umino, Ryosuke and Mizui, Takahiro and Miyata, Akinori and Nara, Satoshi},
  title = {Middle Pancreatectomy for Low‐Grade Malignancies: Superior Long‐Term Glucose Tolerance Preservation Over Distal Pancreatectomy},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  doi = {10.1002/jhbp.70121}
}
Kostenlos starten →